CDKN1C and neoplasm: Within the cytoplasm, LIMK1 may mediate tumor progression via effects on p57Kip2 or serum response factor (SRF), both of which are thought to be directly regulated by cytoplasmic LIMK1 [29,30], and both of which are known to influence tumor biology [31,32].